SUMMARY OF THE PROPOSED COMBINATION (In terms of Regulation 13(1A) of the Competition Commission of India (Procedure in regard to the transaction of business relating to combinations) Regulations, 2011) A. Name of the parties to the combination 1. The Parties to the combination are: a. Kingsman Wealth Fund PCC – Auriss…
SUMMARY OF THE PROPOSED COMBINATION (In terms of Regulation 13(1A) of the Competition Commission of India (Procedure in regard to the transaction of business relating to combinations) Regulations, 2011) A. Name of the parties to the combination 1. The Parties to the combination are: a. Kingsman Wealth Fund PCC – Aurisse Special Opportunities Fund (“Acquirer”); b. Mudhra Lifesciences Private Limited (“Target”) 2. Acquirer and the Target are collectively referred to as the “Parties”. B. Nature and purpose of the combination 3. Acquirer proposes to subscribe to certain securities of the Target, the proceeds of which investment will be utilised by the Target towards the proposed acquisition of Tianish Laboratories Private Limited by Matrix Pharma Private Limited, a step-down subsidiary of the Target (“Proposed Transaction”). 4. The Proposed Transaction amounts to a combination under Section 5(a)(i)(A) of the Competition Act, 2002 (as amended). C. Products, services and business(es) of the parties to the combination 5. Acquirer: The Acquirer holds a Global Business License, issued by the Financial Services Commission, Mauritius. It is regulated by the FSC as an open-ended fund classifying as a self-managed expert fund for the purposes of the Securities Act 2005 and the Securities (Collective Investment Schemes and Closed-End Funds) Regulations 2008. 6. Target: The Target has been incorporated on 5 February 2024 for the purpose of engaging in manufacturing of pharmaceuticals, medicinal chemical and botanical products. The company is yet to commence its operations. D. Relevant market(s) to which the combination relates 7. There are no horizontal, vertical or complementary overlaps in any of the plausible relevant markets in India. 8. Accordingly, the Proposed Transaction does not require the Hon’ble Commission to define any relevant market(s) given that it is unlikely to cause any appreciable adverse effect on competition in any plausible relevant markets in India. E. Green Channel Route 9. Therefore, the Proposed Transaction is being notified under the green channel route in terms of Regulation 5A and Schedule III of the Competition Commission of India (Procedure in regard to the transaction of business relating to combinations) Regulations, 2011 (as amended).
Research the source law
This record is not yet linked to a specific provision. Browse the law library, choose the affected provision and ask against the exact statutory text.
Browse source laws